Literature DB >> 8171392

Activation of apoptosis in early mouse embryos by 2'-deoxyadenosine exposure.

X Gao1, M R Blackburn, T B Knudsen.   

Abstract

Adenosine deaminase (ADA) catalyzes the irreversible hydrolytic deamination of adenosine and deoxyadenosine to nontoxic derivatives. The importance of this reaction in the female reproductive tract of mice is suggested by pronounced utero-placental expression of ADA, and by embryolethality of the potent ADA-inhibitor deoxycoformycin (dCF) on day 7-8 of gestation. The present study investigated the effects of dCF, adenosine, and deoxyadenosine on the mouse neurula. Morphological cell death was monitored by the acridine orange reaction (AOR), and biochemical cell death by internucleosomal DNA cleavage (IDC). A strong AOR appeared in day 7-8 embryos between 3 and 4.5 hr post-exposure to dCF in utero; there was no apparent effect on day 6 or day 9 embryos. Most embryonic tissues were responsive, although the heart and extraembryonic membranes were resistant. Up to 75% of the embryonic chromatin was degraded in a regular pattern in concert with the AOR. Immediate activation of "whole-body" apoptosis was reproduced in short-term whole embryo culture with 0.1 mM deoxyadenosine in the presence of 0.01 mM dCF. This was not activated by exposure to dCF alone nor to adenosine; however, high concentrations of adenosine completely blocked the response to deoxyadenosine, whereas niacinamide inhibited the AOR without changing IDC. The cytotoxic effect of deoxyadenosine was correlated with an expansion of embryonic dATP pools determined by high-performance liquid chromatography analysis. The results suggest that deoxyadenosine is the embryotoxic metabolite which accumulates in the antimesometrium of pregnant mice treated with dCF. Exposure to this metabolic toxin activates apoptosis in day 7-8 embryos through an adenosine-sensitive, NAD-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8171392     DOI: 10.1002/tera.1420490103

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  4 in total

Review 1.  Modulators of nucleoside metabolism in the therapy of brain diseases.

Authors:  Detlev Boison
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

2.  Transcription factor gene AP-2 gamma essential for early murine development.

Authors:  Uwe Werling; Hubert Schorle
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

3.  Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice.

Authors:  M Wakamiya; M R Blackburn; R Jurecic; M J McArthur; R S Geske; J Cartwright; K Mitani; S Vaishnav; J W Belmont; R E Kellems
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

4.  Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.

Authors:  Detlev Boison; Hai-Ying Shen
Journal:  Open Drug Discov J       Date:  2010-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.